Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy
Authors
Keywords
-
Journal
Journal of Cachexia Sarcopenia and Muscle
Volume 8, Issue 2, Pages 298-304
Publisher
Wiley
Online
2016-11-22
DOI
10.1002/jcsm.12161
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015
- (2015) Stephan von Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy
- (2015) Michael P. Chu et al. PLoS One
- Muscle ectopic fat deposition contributes to anabolic resistance in obese sarcopenic old rats through eIF2α activation
- (2014) Nicolas Tardif et al. AGING CELL
- Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies
- (2013) Sami Antoun et al. CANCER
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
- (2013) Lisa Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL
- (2012) C. Muller et al. BLOOD
- Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma
- (2011) Michael S. Sabel et al. ANNALS OF SURGICAL ONCOLOGY
- CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
- (2011) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Markers of Inflammation Are Heritable and Associated with Subcutaneous and Ectopic Skeletal Muscle Adiposity in African Ancestry Families
- (2011) Iva Miljkovic et al. Metabolic Syndrome and Related Disorders
- Lower Physical Activity Is Associated With Higher Intermuscular Adipose Tissue in People With Type 2 Diabetes and Peripheral Neuropathy
- (2011) Lori J. Tuttle et al. PHYSICAL THERAPY
- Epidemiology of myosteatosis
- (2010) Iva Miljkovic et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy*
- (2010) Sari Riihijärvi et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Cachexia as a major underestimated and unmet medical need: facts and numbers
- (2010) Stephan von Haehling et al. Journal of Cachexia Sarcopenia and Muscle
- Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
- (2009) C. M.M. Prado et al. CLINICAL CANCER RESEARCH
- Effects of physical activity on strength and skeletal muscle fat infiltration in older adults: a randomized controlled trial
- (2008) Bret H. Goodpaster et al. JOURNAL OF APPLIED PHYSIOLOGY
- Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
- (2008) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
- (2008) Carla MM Prado et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started